Association of leukocyte telomere length with the risk of digestive diseases: A large-scale cohort study

被引:0
|
作者
Yang Hongqun [1 ]
Chen Lanlan [2 ]
Liu Yahui [1 ]
机构
[1] The Secondary Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin, China
[2] The First Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin,
关键词
Telomere shortening; Digestive system diseases; Leukocyte telomere length; Gastrointestinal diseases; Hepatobiliary diseases;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Leukocyte telomere length (LTL) shortening, a biomarker of telomere attrition, has been linked to multiple diseases. However, the relationship between LTL and digestive diseases remains uncertain. This study aimed to investigate the association between LTL and the risk of digestive diseases.Methods: A cohort analysis of over 500,000 participants from the UK Biobank (UKB) between 2006 and 2021 was conducted to estimate the associations of LTL with more than 90 common digestive diseases. LTL was quantified using multiplex quantitative polymerase chain reaction, and cases of each disease were determined according to inpatient and primary care data. Multivariable Cox proportional hazards regression analysis was used to evaluate the associations of LTL with the risk of digestive diseases. Furthermore, such associations were also evaluated after stratification by sex and ethnicity.Results: After a mean follow-up time of 11.8 years, over 20International Classification of Diseases, 10th Revision (ICD-10) codes were showed to be associated with telomere attrition. LTL shortening is associated with an increased risk of several digestive diseases, including gastroesophageal reflux disease (K21: hazard ratio [HR] = 1.30, 95% confidence interval [95% CI]: 1.19–1.42), esophageal ulcer (K221: HR = 1.81, 95% CI: 1.22–2.71), Barrett’s esophagus (K227: HR = 1.58, 95% CI: 1.14–2.17), gastritis (K29: HR = 1.39, 95% CI: 1.26–1.52), duodenal ulcer (K26: HR = 1.55, 95% CI: 1.14–2.12), functional dyspepsia (K30X: HR = 1.36, 95% CI: 1.06–1.69), non-alcoholic fatty liver disease (NAFLD) (K760: HR = 1.39, 95% CI: 1.09–1.78), liver cirrhosis (K74: HR = 4.73, 95% CI: 3.27–6.85), cholangitis (K830: HR = 2.55, 95% CI: 1.30–5.00), and hernia (K43: HR = 1.50, 95% CI: 1.17–1.94; K44: HR = 1.29, 95% CI: 1.17–1.42). The risk of rectal polyps (K621: HR = 0.77, 95% CI: 0.63–0.92) decreased per unit shortening of LTL.Conclusions: This study suggests that LTL shortening is associated with an increased risk of most digestive diseases except for rectal polyps. These findings may provide some clues for understanding the pathogenesis of digestive diseases.
引用
收藏
相关论文
共 50 条
  • [31] ASSOCIATION BETWEEN LEUKOCYTE TELOMERE LENGTH AND PERSONALITY TRAITS
    Sadahiro, R.
    Suzuki, A.
    Masanori, E.
    Matsumoto, Y.
    Shibuya, N.
    Kamata, M.
    Otani, K.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [32] Association of leukocyte telomere length with perceived physical fatigability
    Katz, Rain
    Gay, Emma L.
    Kuipers, Allison L.
    Lee, Joseph H.
    Honig, Lawrence S.
    Christensen, Kaare
    Feitosa, Mary F.
    Wojczynski, Mary K.
    Glynn, Nancy W.
    EXPERIMENTAL GERONTOLOGY, 2022, 170
  • [33] ASSOCIATION OF LEUKOCYTE TELOMERE LENGTH WITH PERCEIVED PHYSICAL FATIGABILITY
    Katz, Rain
    Zmuda, Joseph
    Lee, Joseph
    Honig, Lawrence
    Christensen, Kaare
    Feitosa, Mary
    Wojczynski, Mary
    Glynn, Nancy W.
    INNOVATION IN AGING, 2021, 5 : 206 - 206
  • [34] PROFILE OF A LARGE-SCALE COHORT STUDY
    FLETCHER, AP
    DRUGS, 1990, 40 : 43 - 47
  • [35] A Multibreed Genome-Wide Association Study for Cattle Leukocyte Telomere Length
    Igoshin, Alexander V.
    Yudin, Nikolay S.
    Romashov, Grigorii A.
    Larkin, Denis M.
    GENES, 2023, 14 (08)
  • [36] Longitudinal decline of leukocyte telomere length in old age and the association with sex and genetic risk
    Berglund, Kari
    Reynolds, Chandra A.
    Ploner, Alexander
    Gerritsen, Lotte
    Hovatta, Iiris
    Pedersen, Nancy L.
    Hagg, Sara
    AGING-US, 2016, 8 (07): : 1398 - 1415
  • [37] Telomere length and the risk of cardiovascular diseases: A Mendelian randomization study
    Deng, Yingjian
    Li, Qiang
    Zhou, Faguang
    Li, Guiyang
    Liu, Jianghai
    Lv, Jialan
    Li, Linlin
    Chang, Dong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [38] Association of relative telomere length with cardiovascular disease in a large chronic kidney disease cohort: The GCKD study
    Raschenberger, Julia
    Kollerits, Barbara
    Titze, Stephanie
    Koettgen, Anna
    Baerthlein, Barbara
    Ekici, Arif B.
    Forer, Lukas
    Schoenherr, Sebastian
    Weissensteiner, Hansi
    Haun, Margot
    Wanner, Christoph
    Eckardt, Kai-Uwe
    Kronenberg, Florian
    ATHEROSCLEROSIS, 2015, 242 (02) : 529 - 534
  • [39] Leukocyte Telomere Length and Bladder Cancer Risk: A Large Case-Control Study and Mendelian Randomization Analysis
    Chen, Meng
    Xu, Yifan
    Xu, Junfeng
    Chancoco, Haidee
    Gu, Jian
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (01) : 203 - 209
  • [40] Leukocyte Telomere Length and Cancer Risk: A Dynamic Problem
    Gu, Jian
    EBIOMEDICINE, 2015, 2 (06): : 493 - +